Breakthrough Nanomedicine Developed to Target HIV in Gene Therapy

Emmanuel Ho, an Associate Professor at the University of Waterloo, has developed a groundbreaking nanomedicine utilizing small interfering RNAs (siRNA) to target HIV in gene therapy. These siRNAs have demonstrated a 73% reduction in HIV replication and the ability to regulate gene and protein activity within cells. This breakthrough paves the way for innovative therapeutics in the battle against HIV. The study, published in the Journal of Controlled Release, marks a significant step forward in the field of nanomedicine for HIV treatment.